From: Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation
Tissue
Recovered mass (ng)
Percent of delivered dose (%)
Lung
3786 ± 540
59.0
Feces
1306 ± 301
20.4
GI tract
69 ± 35
1.1
Liver
15.9 ± 2.4
0.2
Heart
3.5 ± 0.9
< 0.1
Spleen
2.6 ± 0.1
Kidney
2.5 ± 0.4
Blood
1.3 ± 0.8